The immunomodulatory protein B7-H4 is overexpressed in breast and ovarian cancers and promotes epithelial cell transformation

Experimental Cell Research

Volumn 306, Issue 1, 2005, Pages 128-141

  Salceda, Susana ^a   Tang, Tenny ^a   Kmet, Muriel ^a   Munteanu, Andrei ^a   Ghosh, Malavika ^a   Macina, Roberto ^a   Liu, Wenhui ^a   Pilkington, Glenn ^a   Papkoff, Jackie ^a  

^a diaDexus Inc   (United States)

Author keywords

Apoptosis; B7 H4; B7x; Breast cancer; Ovarian cancer

Indexed keywords

CASPASE; CELL SURFACE PROTEIN; CELL SURFACE PROTEIN B7 H4; MESSENGER RNA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANOIKIS; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER GROWTH; CELL SURFACE; CELL TRANSFORMATION; CONTROLLED STUDY; ENZYME ACTIVITY; EPITHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; PROTEIN LOCALIZATION; SCID MOUSE; TISSUE DISTRIBUTION; TUMOR CELL; UPREGULATION;

EID: 18844373949     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2005.01.018     Document Type: Article

References (39)

1. American Cancer Society Cancer statistics 2004
2. V. Kaklamani, and R.M. O'Regan New targeted therapies in breast cancer Semin. Oncol. 31 2004 20 25
3. S. Lo, and S.R. Johnston Novel systemic therapies for breast cancer Surg. Oncol. 12 2003 277 287
4. C.A. Hudis Current status and future directions in breast cancer therapy Clin. Breast Cancer 4 Suppl. 2 2003 S70 S75
5. D.G. Allen, and J. Coulter Survival of patients with epithelial ovarian cancer and the effect of lymphadenectomy in those with stage 3 disease Aust. N. Z. J. Obstet. Gynaecol. 39 1999 420 424
6. A.P. Heintz, F. Odicino, P. Maisonneuve, U. Beller, J.L. Benedet, W.T. Creasman, H.Y. Ngan, and S. Pecorelli Carcinoma of the ovary Int. J. Gynaecol. Obstet. 83 Suppl. 1 2003 135 166
7. J. Engel, R. Eckel, G. Schubert-Fritschle, J. Kerr, W. Kuhn, J. Diebold, R. Kimmig, J. Rehbock, and D. Holzel Moderate progress for ovarian cancer in the last 20 years: prolongation of survival, but no improvement in the cure rate Eur. J. Cancer 38 2002 2435 2445
8. B.M. Carreno, and M. Collins The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses Annu. Rev. Immunol. 20 2002 29 53
9. S.J. Khoury, and M.H. Sayegh The roles of the new negative T cell costimulatory pathways in regulating autoimmunity Immunity 20 2004 529 538
10. X. Zang, P. Loke, J. Kim, K. Murphy, R. Waitz, and J.P. Allison B7x: a widely expressed B7 family member that inhibits T cell activation Proc. Natl. Acad. Sci. U. S. A. 100 2003 10388 10392
11. D.V. Prasad, S. Richards, X.M. Mai, and C. Dong B7S1, a novel B7 family member that negatively regulates T cell activation Immunity 18 2003 863 873
12. G.L. Sica, I.H. Choi, G. Zhu, K. Tamada, S.D. Wang, H. Tamura, A.I. Chapoval, D.B. Flies, J. Bajorath, and L. Chen B7-H4, a molecule of the B7 family, negatively regulates T cell immunity Immunity 18 2003 849 861
13. I.H. Choi, G. Zhu, G.L. Sica, S.E. Strome, J.C. Cheville, J.S. Lau, Y. Zhu, D.B. Flies, K. Tamada, and L. Chen Genomic organization and expression analysis of B7-H4, an immune inhibitory molecule of the B7 family J. Immunol. 171 2003 4650 4654
14. S.M. Elbashir, J. Harborth, W. Lendeckel, A. Yalcin, K. Weber, and T. Tuschl Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells Nature 411 2001 494 498
15. G.J. Hannon RNA interference Nature 418 2002 244 251
16. J. Harborth, S.M. Elbashir, K. Bechert, T. Tuschl, and K. Weber Identification of essential genes in cultured mammalian cells using small interfering RNAs J. Cell Sci. 114 2001 4557 4565
17. J.S. Michaelson, and P. Leder RNAi reveals anti-apoptotic and transcriptionally repressive activities of DAXX J. Cell Sci. 116 2003 345 352
18. B. Tringler, S. Zhuo, G. Pilkington, K. Torkko, M. Singh, M.S. Lucia, D.E. Heinz, J. Papkoff, K.R. Shroyer, B7-H4 is highly expressed in ductal and lobular breast cancer. Clinical Cancer Research, in press.
19. N.O. Concha, and S.S. Abdel-Meguid Controlling apoptosis by inhibition of caspases Curr. Med. Chem. 9 2002 713 726
20. F.L. Kiechle, and X. Zhang Apoptosis: biochemical aspects and clinical implications Clin. Chim. Acta 326 2002 27 45
21. I.D. Louro, P. McKie-Bell, H. Gosnell, B.C. Brindley, R.P. Bucy, and J.M. Ruppert The zinc finger protein GLI induces cellular sensitivity to the mTOR inhibitor rapamycin Cell Growth Differ. 10 1999 503 516
22. Z. Weng, M. Xin, L. Pablo, D. Grueneberg, M. Hagel, G. Bain, T. Muller, and J. Papkoff Protection against anoikis and down-regulation of cadherin expression by a regulatable beta-catenin protein J. Biol. Chem. 277 2002 18677 18686
23. T. Muller, G. Bain, X. Wang, and J. Papkoff Regulation of epithelial cell migration and tumor formation by beta-catenin signaling Exp. Cell Res. 280 2002 119 133
24. J. Deshane, G. Cabrera, J.E. Grim, G.P. Siegal, J. Pike, R.D. Alvarez, and D.T. Curiel Targeted eradication of ovarian cancer mediated by intracellular expression of anti-erbB-2 single-chain antibody Gynecol. Oncol. 59 1995 8 14
25. U.B. Nielsen, G.P. Adams, L.M. Weiner, and J.D. Marks Targeting of bivalent anti-ErbB2 diabody antibody fragments to tumor cells is independent of the intrinsic antibody affinity Cancer Res. 60 2000 6434 6440
26. B. Tringler, W. Liu, L. Corrall, K. Torkko, T. Enomoto, S. Davidson, M.S. Lucia, D.E. Heinz, J. Papkoff, K.R. Shroyer, B7-H4 overexpression in ovarian cancer. (Submitted for publication).
27. B. Aunoble, R. Sanches, E. Didier, and Y.J. Bignon Major oncogenes and tumor suppressor genes involved in epithelial ovarian cancer (review) Int. J. Oncol. 16 2000 567 576
28. S.V. Nicosia, W. Bai, J.Q. Cheng, D. Coppola, and P.A. Kruk Oncogenic pathways implicated in ovarian epithelial cancer Hematol. Oncol. Clin. North Am. 17 2003 927 943
29. R. Wu, Y. Zhai, E.R. Fearon, and K.R. Cho Diverse mechanisms of beta-catenin deregulation in ovarian endometrioid adenocarcinomas Cancer Res. 61 2001 8247 8255
30. N. Watanabe, M. Gavrieli, J.R. Sedy, J. Yang, F. Fallarino, S.K. Loftin, M.A. Hurchla, N. Zimmerman, J. Sim, X. Zang, T.L. Murphy, J.H. Russell, J.P. Allison, and K.M. Murphy BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1 Nat. Immunol. 4 2003 670 679
31. J.R. Sedy, M. Gavrieli, K.G. Potter, M.A. Hurchla, R.C. Lindsley, K. Hildner, S. Scheu, K. Pfeffer, C.F. Ware, T.L. Murphy, and K.M. Murphy B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator Nat. Immunol. 6 2005 90 98
32. H. Dong, S.E. Strome, D.R. Salomao, H. Tamura, F. Hirano, D.B. Flies, P.C. Roche, J. Lu, G. Zhu, K. Tamada, V.A. Lennon, E. Celis, and L. Chen Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion Nat. Med. 8 2002 793 800
33. S.C. Liang, Y.E. Latchman, J.E. Buhlmann, M.F. Tomczak, B.H. Horwitz, G.J. Freeman, and A.H. Sharpe Regulation of PD-1, PD-L1, and PD-L2 expression during normal and autoimmune responses Eur. J. Immunol. 33 2003 2706 2716
34. P. Loke, and J.P. Allison PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells Proc. Natl. Acad. Sci. U. S. A. 100 2003 5336 5341
35. S.E. Strome, H. Dong, H. Tamura, S.G. Voss, D.B. Flies, K. Tamada, D. Salomao, J. Cheville, F. Hirano, W. Lin, J.L. Kasperbauer, K.V. Ballman, and L. Chen B7-H1 blockade augments adoptive T-cell immunotherapy for squamous cell carcinoma Cancer Res. 63 2003 6501 6505
36. S. Wintterle, B. Schreiner, M. Mitsdoerffer, D. Schneider, L. Chen, R. Meyermann, M. Weller, and H. Wiendl Expression of the B7-related molecule B7-H1 by glioma cells: a potential mechanism of immune paralysis Cancer Res. 63 2003 7462 7467
37. H. Tamura, K. Ogata, H. Dong, and L. Chen Immunology of B7-H1 and its roles in human diseases Int. J. Hematol. 78 2003 321 328
38. C. Blank, I. Brown, A.C. Peterson, M. Spiotto, Y. Iwai, T. Honjo, and T.F. Gajewski PD-L1/B7H-1 inhibits the effector phase of tumor rejection by T cell receptor (TCR) transgenic CD8+ T cells Cancer Res. 64 2004 1140 1145
39. C.E. Rudd, and H. Schneider Unifying concepts in CD28, ICOS and CTLA4 co-receptor signalling Nat. Rev., Immunol. 3 2003 544 556